Symptoms primarily based in Porto, European country are authorized to cultivate, import and export medical Cannabis sativa L, with their facility that features indoor, outside and greenhouse cultivation, analysis and internal control labs moreover as process, packaging, and distribution for medical cannabis and cannabinoid-containing product, totaling 105 hectares with 95 hectares approved for cultivation is Europe’s largest outdoor medical cannabis cultivation facility, capable of manufacturing about 700,000 kilograms per annum.
With Symtomax wanting to speculate over €30m over the ensuing 5 years guaranteeing that they lead the cultivation method in Europe.
Syntax is managed by corporate executive and Founder Minette Coetzee, whose entrepreneurial instincts and vision have speedily positioned them as a serious powerhouse within the cultivation world at intervals the EU Union. a powerful team, with the likes of Eurico Ilich Ramirez Sanchez Alves a prof of Surgery at the Integrated Master of medication of the Institute of medical specialty Sciences and former State Secretary of Health and Chairman of the Infarmed Board of administrators. David Mace, ex GW pharmaceutical Audit Chairman, and Olaf van Tulder corporate executive of inexperienced House group (strain hunters) and over 25 years’ expertise within the cultivation of cannabis on a billboard level.
This formidable partnership established between Symtomax and inexperienced House group (GHM Europe B.V.) who are based mostly in the national capital are one amongst the world’s leading producers, processors, extractors and breeders of medicative grade cannabis biology for the supplement, cosmetics, and pharmaceutical industries, has ensured Symtomax’s standing amongst the foremost cannabis firms in Europe.